Scarica l'app Stockscreener
51.63
0.19%
0.10
Dopo l'orario di chiusura:
51.71
0.08
+0.15%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché VKTX Giù?
Forum
Previsione
Viking Therapeutics Inc Borsa (VKTX) Ultime notizie
Do Redditors Think That Viking Therapeutics Inc. (VKTX) Has a Big Upside Potential? - Insider Monkey
Viking Therapeutics (NASDAQ:VKTX) Shares Up 0.3%Here's What Happened - MarketBeat
Royce & Associates LP Purchases Shares of 13,334 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics is more than just a weight-loss stock, and that’s drawing cheers - MSN
NASH Updates: Boston Pharma, Viking Line Up As Serious Competitors - Citeline News & Insights
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 0.5%Here's What Happened - MarketBeat
Viking Therapeutics Garners Analyst Support For NASH And Metabolic Programs - Yahoo Finance
Viking Therapeutics (NASDAQ:VKTX) Earns Outperform Rating from William Blair - MarketBeat
Viking Therapeutics Presents Results from Phase 2b VOYAGE Study of VK2809 in Biopsy-Confirmed NASH/MASH at the 75th Liver Meeting® 2024 - The Malaysian Reserve
JW Asset Management LLC Makes New Investment in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics Stock Swings Wildly After Weight-Loss Drug Data - MSN
Is It Too Late to Buy Viking Therapeutics Stock? - MSN
Viking phase 2b study of NASH candidate hits primary endpoint - Seeking Alpha
Viking Therapeutics (NASDAQ:VKTX) Trading Down 1%Here's Why - MarketBeat
3 Things You Need to Know if You Buy Viking Therapeutics Today - AOL
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Viking Therapeutics, Inc.VKTX - PR Newswire
Viking Therapeutics (NASDAQ:VKTX) Shares Down 1.4%Here's What Happened - MarketBeat
What the Options Market Tells Us About Viking Therapeutics - Benzinga
Viking Therapeutics Insiders Sold US$8.9m Of Shares Suggesting Hesitancy - Simply Wall St
Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat
3 Growth Stocks That Have Generated 1,000% Returns Since the Last Presidential Election (and They've All Outperformed Nvidia) - AOL
LJI Wealth Management LLC Has $1.17 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. - AOL
Prediction: Acquisitions Will Skyrocket Under The Trump Administration. Here's 1 Pharmaceutical Company I Have My Eyes On. - The Motley Fool
Viking Therapeutics (NASDAQ:VKTX) Shares Down 2.9%Should You Sell? - MarketBeat
Market Whales and Their Recent Bets on VKTX Options - Benzinga
Oppenheimer & Co. Inc. Has $6.48 Million Holdings in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Aptus Capital Advisors LLC Purchases 9,699 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Sigma Planning Corp Acquires Shares of 15,119 Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Amgen Rebounds. But Do Eli Lilly And Viking Therapeutics Now Have The Upper Hand? - Yahoo! Voices
Viking Therapeutics (NASDAQ:VKTX) Shares Down 3.1%Here's Why - MarketBeat
Did Viking Therapeutics Just Say "Checkmate" To Eli Lilly? - sharewise
Chartwell Investment Partners LLC Acquires 17,159 Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Is Viking Therepautics a Buy Now? - AOL
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 5.6%What's Next? - MarketBeat
Viking Therapeutics to Present Key NASH Drug Trial Results at Major Liver Meeting | VKTX Stock News - StockTitan
Viking Therapeutics (VKTX) Shares Cross Below 200 DMA - Nasdaq
Principal Financial Group Inc. Has $37.58 Million Stock Position in Viking Therapeutics, Inc. (NASDAQ:VKTX) - MarketBeat
Viking Therapeutics (NASDAQ:VKTX) Trading Down 2.2% After Insider Selling - MarketBeat
Is Viking Therapeutics a Buy on the Dip? - sharewise
291,318 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Purchased by Fiera Capital Corp - MarketBeat
Insider Selling: Viking Therapeutics, Inc. (NASDAQ:VKTX) Director Sells 2,000 Shares of Stock - MarketBeat
Viking Therapeutics director sells $137,333 in stock - Investing.com
Viking Therapeutics (NASDAQ:VKTX) Stock Price Down 0.8%What's Next? - MarketBeat
Viking Therapeutics, Inc. (NASDAQ:VKTX) is Quantum Private Wealth LLC's 10th Largest Position - MarketBeat
4 Reasons Why Buying Viking Therapeutics Stock Right Now Is a Smart Move - sharewise
Viking Therapeutics Tumbles As Obesity Competition Sabotages Its Novo Nordisk Beat - MSN
Got $5,000? Viking Therapeutics Stock Just Got a Big New Green Flag - MSN
Viking Therapeutics’ weight-loss pill shows ‘great outcome’ in trial - MSN
Viking Therapeutics (VKTX) Stock Surges on Promising Treatment Pipeline - Nasdaq
Viking Therapeutics Shines With Promising Results For New Obesity Drug - Finimize
Viking Therapeutics reports positive data from trial of treatment for rare metabolic disorder X-ALD - MSN
Non-Alcoholic Steatohepatitis Market to Show Remarkable Growth Trends from 2023 to 2032, DelveInsight Reports | Inventiva Pharma, Zydus Therapeutics, Novo Nordisk A/S, Viking Therapeutics, Madrigal - Barchart
Viking Therapeutics Offers An Obesity Drug for Healthy Adults - Yahoo Finance
0.93%
3.55%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):